Cancer patients with detectable scIgGs in tumors also trended lower survival rate (86.98% vs 90.36%, p = 0.216) than those patients with no detectable scIgGs in tumor tissues, but it did not reach statistical significance (Supplementary Fig.
← all excerpts
Impairment of IgG Fc functions promotes tumor progression and suppresses NK cell antitumor actions.
1
—
—